361 related articles for article (PubMed ID: 31137622)
21. Stimuli-responsive Polymeric Nanosystems for Therapeutic Applications.
Handa M; Singh A; Flora SJS; Shukla R
Curr Pharm Des; 2022; 28(11):910-921. PubMed ID: 34879797
[TBL] [Abstract][Full Text] [Related]
22. Environment-Responsive Therapeutic Platforms for the Treatment of Implant Infection.
Hu Y; Li S; Dong H; Weng L; Yuwen L; Xie Y; Yang J; Shao J; Song X; Yang D; Wang L
Adv Healthc Mater; 2023 Oct; 12(26):e2300985. PubMed ID: 37186891
[TBL] [Abstract][Full Text] [Related]
23. Engineering dynamic covalent bond-based nanosystems for delivery of antimicrobials against bacterial infections.
Tageldin A; Omolo CA; Nyandoro VO; Elhassan E; Kassam SZF; Peters XQ; Govender T
J Control Release; 2024 Jul; 371():237-257. PubMed ID: 38815705
[TBL] [Abstract][Full Text] [Related]
24. Stimuli-Responsive Nanoparticles for siRNA Delivery.
Eloy JO; Petrilli R; Lopez RF; Lee RJ
Curr Pharm Des; 2015; 21(29):4131-44. PubMed ID: 26323434
[TBL] [Abstract][Full Text] [Related]
25. An Overview of Stimuli-Responsive Intelligent Antibacterial Nanomaterials.
Zhang J; Tang W; Zhang X; Song Z; Tong T
Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631327
[TBL] [Abstract][Full Text] [Related]
26. Endogenous and Exogenous Stimuli-Responsive Drug Delivery Systems for Programmed Site-Specific Release.
Raza A; Rasheed T; Nabeel F; Hayat U; Bilal M; Iqbal HMN
Molecules; 2019 Mar; 24(6):. PubMed ID: 30901827
[TBL] [Abstract][Full Text] [Related]
27. Promising advances in nanobiotic-based formulations for drug specific targeting against multidrug-resistant microbes and biofilm-associated infections.
Elfadil D; Elkhatib WF; El-Sayyad GS
Microb Pathog; 2022 Sep; 170():105721. PubMed ID: 35970290
[TBL] [Abstract][Full Text] [Related]
28. Stimuli-responsive metal-organic framework nanoparticles for controlled drug delivery and medical applications.
Zhou Z; Vázquez-González M; Willner I
Chem Soc Rev; 2021 Apr; 50(7):4541-4563. PubMed ID: 33625421
[TBL] [Abstract][Full Text] [Related]
29. Fighting Methicillin-Resistant
Andrade S; Ramalho MJ; Santos SB; Melo LDR; Santos RS; Guimarães N; Azevedo NF; Loureiro JA; Pereira MC
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240376
[TBL] [Abstract][Full Text] [Related]
30. Progress of stimulus responsive nanosystems for targeting treatment of bacterial infectious diseases.
Yang N; Sun M; Wang H; Hu D; Zhang A; Khan S; Chen Z; Chen D; Xie S
Adv Colloid Interface Sci; 2024 Feb; 324():103078. PubMed ID: 38215562
[TBL] [Abstract][Full Text] [Related]
31. Stimuli-sensitive nano-drug delivery with programmable size changes to enhance accumulation of therapeutic agents in tumors.
Souri M; Kiani Shahvandi M; Chiani M; Moradi Kashkooli F; Farhangi A; Mehrabi MR; Rahmim A; Savage VM; Soltani M
Drug Deliv; 2023 Dec; 30(1):2186312. PubMed ID: 36895188
[TBL] [Abstract][Full Text] [Related]
32. A review of stimuli-responsive nanocarriers for drug and gene delivery.
Ganta S; Devalapally H; Shahiwala A; Amiji M
J Control Release; 2008 Mar; 126(3):187-204. PubMed ID: 18261822
[TBL] [Abstract][Full Text] [Related]
33. Polymeric nano- and microparticulate drug delivery systems for treatment of biofilms.
Birk SE; Boisen A; Nielsen LH
Adv Drug Deliv Rev; 2021 Jul; 174():30-52. PubMed ID: 33845040
[TBL] [Abstract][Full Text] [Related]
34. Stimuli-responsive nanocarrier delivery systems for Pt-based antitumor complexes: a review.
Wang T; Wu C; Hu Y; Zhang Y; Ma J
RSC Adv; 2023 May; 13(24):16488-16511. PubMed ID: 37274408
[TBL] [Abstract][Full Text] [Related]
35. Stimuli-responsive drug delivery systems for head and neck cancer therapy.
Liang J; Yang B; Zhou X; Han Q; Zou J; Cheng L
Drug Deliv; 2021 Dec; 28(1):272-284. PubMed ID: 33501883
[TBL] [Abstract][Full Text] [Related]
36. pH-Responsive Lipid-Dendrimer Hybrid Nanoparticles: An Approach To Target and Eliminate Intracellular Pathogens.
Maji R; Omolo CA; Agrawal N; Maduray K; Hassan D; Mokhtar C; Mackhraj I; Govender T
Mol Pharm; 2019 Nov; 16(11):4594-4609. PubMed ID: 31593478
[TBL] [Abstract][Full Text] [Related]
37. Pd-Cu nanoalloy for dual stimuli-responsive chemo-photothermal therapy against pathogenic biofilm bacteria.
Wang Z; Peng Y; Zhou Y; Zhang S; Tan J; Li H; He D; Deng L
Acta Biomater; 2022 Jan; 137():276-289. PubMed ID: 34715367
[TBL] [Abstract][Full Text] [Related]
38. Targeted Drug Delivery Systems for Eliminating Intracellular Bacteria.
Feng W; Chittò M; Moriarty TF; Li G; Wang X
Macromol Biosci; 2023 Jan; 23(1):e2200311. PubMed ID: 36189899
[TBL] [Abstract][Full Text] [Related]
39. Nanoantibiotics to fight multidrug resistant infections by Gram-positive bacteria: hope or reality?
Berini F; Orlandi V; Gornati R; Bernardini G; Marinelli F
Biotechnol Adv; 2022; 57():107948. PubMed ID: 35337933
[TBL] [Abstract][Full Text] [Related]
40. Triclosan-based supramolecular hydrogels as nanoantibiotics for enhanced antibacterial activity.
Yang L; Zhang C; Huang F; Liu J; Zhang Y; Yang C; Ren C; Chu L; Liu B; Liu J
J Control Release; 2020 Aug; 324():354-365. PubMed ID: 32454121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
